Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Monocyte chemoattractant protein-1 (MCP-1), acting through its C-C
chemokine receptor 2
(
CCR-2
), has important roles in inflammation, angiogenesis, and wound repair. The individual and combined effects of inhaled nitric oxide (NO) and
hyperoxia
on lung MCP-1 and
CCR-2
in relation to lung leukocyte dynamics are unknown. Because MCP-1 gene is up-regulated by oxidants, we hypothesized that inhaled NO with
hyperoxia
will increase MCP-1 production and
CCR-2
expression more than either gas alone. We randomly assigned young piglets to breathe room air (RA), RA+50 ppm NO (RA+NO), O(2), or O(2)+NO for 1 or 5 d before sacrifice. Lungs were lavaged and tissues preserved for hybridization studies, Western blotting, histology, and immunohistochemistry. The results show that lung MCP-1 production and alveolar macrophage count were significantly elevated in the 5-d O(2) and O(2)+NO groups relative to the RA group (p < or = 0.05). In contrast, lung
CCR-2
abundance was diminished in the O(2) group (p </= 0.05), but not in the O(2)+NO group, compared with the RA group. No difference was detected in any variable studied at 24 h.
CCR-2
distribution was similar in all groups with staining of alveolar septa, macrophages, vascular endothelium, and the luminal epithelial surface of airways. We conclude that although
hyperoxia
increases MCP-1 in young piglet lungs, it also decreases
CCR-2
abundance, which may limit participation of MCP-1 in alveolar macrophage recruitment. Inhaled NO, unlike
hyperoxia
, has no significant independent effect, but its concurrent administration during
hyperoxia
attenuates the decremental effect of
hyperoxia
on
CCR-2
abundance.
...
PMID:Monocyte chemoattractant protein-1 and its receptor CCR-2 in piglet lungs exposed to inhaled nitric oxide and hyperoxia. 1164 60
To clarify the role of the monocyte chemoattractant protein-1 (MCP-1)/C-C
chemokine receptor 2
(
CCR2
) signalling pathway in
hyperoxia
-induced acute lung injury,
CCR2
-deficient (
CCR2
-/-) and wild-type (CCR2+/+) mice were exposed to 85% O(2) for up to 6 days. At day 3, body weight significantly decreased and total protein concentration in bronchoalveolar lavage fluid (BALF) was higher in
CCR2
-/- mice compared with CCR2+/+ mice. Cumulative survivals were significantly lower in
CCR2
-/- mice than in CCR2+/+ mice. However, the two groups showed no significant differences in both histological changes and number of macrophages in BALF. Real-time reverse transcriptase-polymerase chain reaction revealed increased mRNA levels of MCP-1, interleukin-1beta thioredoxin-1, and inducible nitric oxide synthase (iNOS) in lung tissues in
CCR2
-/- mice compared with CCR2+/+ mice. Increased iNOS mRNA levels in alveolar macrophages exposed to 85% O(2) for 48 h in vivo or in vitro were significantly higher in
CCR2
-/- mice than in CCR2+/+ mice. These results suggest that the MCP-1/
CCR2
signalling pathway is protective against
hyperoxia
-induced tissue injury by suppressing induction of iNOS and consequent production of reactive oxygen species by activated alveolar macrophages.
...
PMID:MCP-1/CCR2 signalling pathway regulates hyperoxia-induced acute lung injury via nitric oxide production. 1722 15